Cadila Pharmaceuticals Limited has a dedicated Diabetology Portfolio.

Named "Pharma Diabetology" with the theme "Sweetness of Living", this cell offers primarily a basic product basket comprising Oral antidiabetics, viz. Sulphonylureas, Biguanides, Combination drugs and Insulins.

Cadila Pharmaceuticals Limited has already entered into a technology transfer agreement for Insulin with M/S Polfa Tarchomin, Poland. Polfa markets insulins since 1924 and offers Insulin in various Pharmacokinetic forms such as Chromatographically Purified and Highly Purified preparations.

Cadila Pharmaceuticals Limited intends to create a distinct identity in the Indian Diabetic care market by promoting the theme of "Sweetness of Living" through unique customer friendly promotional strategies.